Elsevier MDL releases MDL® Logistics 1.2
Comprehensive e-procurement platform for chemicals improves R&D efficiency and productivity
San Ramon, CA – June 26, 2007 – Elsevier MDL has released MDL®Logistics 1.2, the complete solution for managing reagent procurement and inventory tracking in biopharmaceutical and chemical research centers. MDL Logistics 1.2 contains powerful new features and content designed to help customers effectively manage internal chemical inventories and commercial supplier catalog data.
These features include full compatibility with the MDL® Isentris® 2.0 system, which makes MDL Logistics 1.2 an integral part of a modern research environment that delivers the information scientists need to work smarter, faster and more efficiently. Furthermore, MDL Logistics 1.2 streamlines workflows and saves time by automating the inventory reconciliation process, by providing out-of-the-box regulatory reports and by offering enhanced printing and data import/export capabilities.
In addition, full integration with MDL® Available Chemicals Directory on MDL® Direct 6.0 provides access to over 700 electronic chemical supplier catalogs. Researchers can track reagents from procurement through disposal in a workflow that supports both corporate and regulatory requirements. No other solution on the market today provides such comprehensive coverage of commercially available compounds.
“Inventory management is a business critical operation, and MDL Logistics helps customers get it right with minimal effort,” said Dr. Trevor Heritage, Senior Vice President and Chief Scientific Officer, Elsevier MDL. “This complete, flexible inventory management solution, built on the MDL Isentris system, provides an out-of-the-box solution for scientific R&D groups and can be easily customized to meet the needs of large organizations.”
MDL Logistics integrates with enterprise procurement solutions such as SAP, Ariba, Oracle® iProcurement and Microsoft® Business Solutions-Axapta® software. Critical purchasing system integration supports on-contract spending while simultaneously promoting simplified workflows, decreased cycle times and faster time-to-market.
With MDL Logistics, scientists can view and manipulate data faster using similarity searching, filtering techniques and convenient look-up fields. The enhanced user interface makes it easier to transfer containers, cherry-pick compounds, save frequently used queries or lists and generate inventory reports. The system provides automated workflows for container tracking, global inventory operations and the handling of regulated or controlled substances. Out-of-the-box integration with laboratory hardware such as barcode readers and balances can be extended to include personal digital assistants, further streamlining the management of real-time data.
For more information about the MDL Logistics total procurement solution, visit www.mdl.com or contact an Elsevier MDL Account Manager to arrange a demonstration.
About Elsevier MDL
Elsevier MDL provides informatics, database and workflow solutions that accelerate successful scientific R&D by improving the speed and quality of scientists’ decision making. Researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com. Elsevier is a world-leading publisher of scientific, technical and medical information products and services.
Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). For more information, visit www.reedelsevier.com.
Senior Director, Marketing Communications
Phone: (925) 543-5400
MDL, Isentris and Available Chemicals Directory are registered trademarks or trademarks of MDL Information Systems, Inc. (‘Elsevier MDL’) in the United States and/or other countries. Ariba is a trademark of Ariba. Oracle is a registered trademark of the Oracle Corporation in the United States and/or other countries. Microsoft and Axapta are registered trademarks of the Microsoft Corporation in the United States and other countries. SAP is a trademark or registered trademark of SAP AG in Germany and several other countries. Use of these third party trademarks is for informational purposes only and does not imply endorsement of Elsevier MDL or its products. All other trademarks mentioned in this document are the property of their respective owners. All rights reserved.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.